Bioquell was approached by a multinational bio-pharmaceutical company to provide remediation planning in case of a breach of sterility or contamination event across their 4 European sites. A Bioquell specialist visited each production site in turn in order to establish an emergency Hydrogen Peroxide Vapor decontamination protocol to be implemented in the event of a contamination incident. Working […]Read More
The Polish subsidiary of a major international generics and specialty pharmaceutical manufacturer has chosen a Bioquell Qube M-11 system to provide the ideal environment for carrying out its product sterility testing. Previously, the quality department had been performing sterility testing utilising a laminar flow system and cleanroom for product protection. The critical nature of such testing and the […]Read More
Candida auris is an emerging pathogen with a high level of resistance to standard anti-fungal treatments. It is a causative agent of candidiasis, which when systemic (i.e. within the bloodstream) can result in high levels of mortality. The US CDC released guidance last year on the reporting, diagnosis, treatment and control of C.auris. On the 16th February, […]Read More
Leading Biodecontamination experts Bioquell warmly welcomes the latest publication by the HSE highlighting the timescale for hydrogen peroxide-based biocides to be compliant. The HSE Biocides e-Bulletin 22 September 2016 is entitled ‘Active Substance Approval Reminder’ and summarises all of the key dates for the evaluation of hydrogen peroxide in Product Types 1, 2, 3, 4, […]Read More
A multi-national vaccine manufacturer approached Bioquell in order to perform a Biodecontamination within its FDA approved facility. The facility itself, some 5,500 cubic meters, was treated as a single Biodecontamination enclosure with the entire process completed within 30 hours. After a successful deployment of the project,the customer contacted Bioquell wishing to establish an industry leading […]Read More
Visit Bioquell at booth 1102 at APIC which will bring together professionals in infection control to discuss the latest trends and initiatives within the healthcare environment.
Visit Bioquell at ISCT 2018 which will bring together clinicians, researchers, regulators, and technologists with a shared vision to translate cellular therapy into safe and effective therapies to improve patients’ lives worldwide.